Noven Pharmaceuticals gets FDA approvable letter for Stavzor

Tue Oct 23, 2007 6:04pm EDT

Oct 23 (Reuters) - Noven Pharmaceuticals Inc NOVN.O said it received an approvable letter from the U.S. health regulators for its potential treatment for bipolar disorder, migraine and epilepsy. The drugmaker said the U.S. Food and Drug Administration requested certain non-clinical information, as a condition for final approval of Stavzor. Noven said it expects Stavzor to get final approval by the end of July 2008. (Reporting by Esha Dey in Bangalore)